Marc E. Lippman, Director at SEATTLE GENETICS INC /WA (SGEN), bought 20,000 shares at $12.49 ($250K) on 2010-06-04, disclosed to the SEC on 2010-06-08.
Open-market purchase of $250k SGEN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SGEN | SELL | 2019-11-20 | $6.1M | — | Filing → |
| SGEN | SELL | 2018-08-02 | $512K | — | Filing → |
| SGEN | SELL | 2017-11-17 | $174K | — | Filing → |